A nanostructured black TiO2 photoelectrocatalytic device designed as a kitchen mop that generates multiple radicals in a thin water film to inactivate biological pathogens on solid surfaces. The system uses broad-spectrum light and low bias voltage with ions in tap water as radical source material, enabling chemical-free surface disinfection for healthcare, food service, and consumer applications.
This technology is a photoelectrocatalytic surface disinfection device built around a nanostructured black TiO2 material that generates multiple reactive radicals when activated by light and a low bias voltage. Designed in the form of a kitchen mop, the device creates a thin film of ion-containing water between the material and a contaminated surface, producing radicals that inactivate biological pathogens such as bacteria and viruses. By leveraging ions naturally present in tap water as the radical source material, the system achieves disinfection without requiring added chemical sanitizers.
The approach addresses the need for effective, chemical-free surface decontamination across settings including healthcare facilities, food preparation areas, laboratories, and consumer environments. Unlike traditional disinfection methods that rely on chemical agents, this device uses photocatalytic oxidation to neutralize pathogens on contact.
Core technology:
Operating parameters validated in laboratory testing:
Radical generation mechanism:
The technology is currently at an early-to-mid stage of development. The core black TiO2 photoelectrocatalytic material has been validated in a reactor configuration for water purification, demonstrating effective inactivation of coliform bacteria under controlled illumination and bias conditions. Published results confirm the relationship between light intensity, applied voltage, and pathogen inactivation efficacy.
Next-phase development will focus on two aims: first, synthesizing the nanostructured black TiO2 material and integrating it into a functional mop-like device with an integrated light source and spray nozzle; second, testing the device's effectiveness against a broader range of pathogens including E. coli, cryptosporidium, and avian coronavirus, with systematic exploration of exposure time and light intensity parameters. The device is not yet commercially available and requires prototype fabrication and expanded pathogen validation before market readiness.
The University of Utah is a comprehensive public research university in Salt Lake City, paired with the resources of a major academic medical center. Industry partners engage through an on-campus research and technology park that co-locates companies with faculty labs and shared core facilities. Clinical integration supports large-scale trials and translation, while proximity to Silicon Slopes expands access to regional innovation partners. Research is supported by competitive federal funding from NIH and NSF, with additional awards from DOE and the Department of Defense. A dedicated technology commercialization office manages IP, licensing, startup formation, and corporate engagement, with incubator space in the research park.